Leveraging biomimicry & evidence-based medicine

Patient-Focused
Biomimicry
Evidence-Based Medicine
brain campus picture
© Thomas Ott, BRAIN Biotech AG
Our Focus

Our Story

The company was born in 2017 as a spin-off from BRAIN Biotech AG, a leading German biotech company that focuses on harnessing biological diversity to develop innovative solutions.

Meet our team
Management Team
Dr. Sam Bakri
EXECUTIVE CHAIRMAN & CEO
Dr. David Goldsmith
CHIEF MEDICAL OFFICER
Dr. Bela Kelety
CHIEF TECHNOLOGY OFFICER
Benjamin Newmark
PRESIDENT & CHIEF FINANCIAL OFFICER
Lily Bouzelmat
CHIEF DEVELOPMENT OFFICER
Frank Goebel
CHIEF BUSINESS OFFICER
Meet our team
Board of Directors

Dr. Sam Bakri
Chairman

Sam is a serial healthcare entrepreneur. He was the CEO and co-founder of Kind Consumer, a UK-based medical technology company, the co-founder of AIDA Health (backed by Mayo Clinic) and Gelmetix Healthcare, where he is Vice Chairman.

Adriaan Moelker
Director

Adriaan is the CEO of BRAIN Biotech AG. Before joining BRAIN Biotech AG, he held a wide variety of management positions during his 30-year career, and his particular focus has been on Biotechnology.

Dr. Charles Bruce
Director

Charles is Associate Medical Director for Mayo Clinic Ventures. He is a Professor of Medicine in the Division of Cardiovascular Diseases, Mayo Clinic College of Medicine.

Dan Wright
Director

Dan was a founding partner and COO of NorthEdge Capital, a U.K. mid-market buyout firm focused on investments in the North of England. He serves as SolasCure’s independent Board member, focused on governance issues.

François Fournier
Director

François is CEO & President of Virbac. He is the former head of Wound Care and former head of Asia-Pac at Smith & Nephew. François has been in the industry for about 20 years with worldwide experience in the pharmaceutical industry in a multi-business environment, creating and growing markets in North America, Europe, Middle East Africa, Asia, and Latin America.

 

Frank Goebel
Director

Frank is the former CFO of BRAIN Biotech AG. He previously spent 15 years in Structured Finance at a global investment bank. Formerly a controller in a German industrial company.

Riad Armanious
Director

Riad is the CEO of Eva Pharma, one of the leading specialty pharma companies in Africa. Riad is active in the YPO (Young Presidents Association), the “T20” foundation and Vice Chairman in the Egyptian Industrial Chamber of Pharmaceuticals.

Mission & Values

Our mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds

Patient-focused

Our research is focused on ways to deliver wound care treatments for patients in an outpatient or home setting

Biomimicry

By learning from nature and harnessing its power, we are seeking solutions for patients

Evidence-based medicine

Our scientific programme is shaped by cutting-edge research that aims to provide targeted therapies to help relieve suffering